 | • レポートコード：TPM-NV164 • 出版社/出版日：Transparency Market Research / 2019年10月28日 • レポート形態：英文、PDF、189ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、ヘモグロビンA1cテストの世界市場について調べ、ヘモグロビンA1cテストの世界市場規模、市場動向、市場シェア、市場環境、市場予測、技術別（イオン交換高速液体クロマトグラフィー（HPLC）、イムノアッセイ、ボロン酸親和性クロマトグラフィー、直接酵素アッセイ、その他）分析、エンドユーザー別（臨床検査（商業研究所、その他）、ポイントオブケア（POC）検査[病院、在宅ケア、クリニック、その他））分析、関連企業情報などをまとめました。 ・ヘモグロビンA1cテストの市場概要 ・ヘモグロビンA1cテストの市場動向 ・ヘモグロビンA1cテストの世界市場規模・予測 ・ヘモグロビンA1cテスト市場：技術別（イオン交換高速液体クロマトグラフィー（HPLC）、イムノアッセイ、ボロン酸親和性クロマトグラフィー、直接酵素アッセイ、その他） ・ヘモグロビンA1cテスト市場：エンドユーザー別（臨床検査（商業研究所、その他）、ポイントオブケア（POC）検査[病院、在宅ケア、クリニック、その他）） ・地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争環境・関連企業分析 |
The rising prevalence of diabetes mellitus has triggered the need for efficacious diabetes management testing solutions. Due to the growing awareness amongst consumers about the availability of testing options, manufacturers in the hemoglobin A1c testing market are increasing their production capabilities for the development of testing solutions that help track and manage glucose levels. For instance, in June 2019, Abbot – a leading American medical devices and healthcare company, announced the launch of Afinion™ HbA1c Dx assay- a first-of-its-kind, FDA-approved rapid point-of-care test that delivers accurate and precise results for diabetes management.
Other drivers that have catalyzed the need for testing solutions in the hemoglobin A1c testing market are health complications of retinopathy, neuropathy, and cardiovascular diseases due to inefficient management of glucose levels. To comply with the stringent regulations laid down by health commissions, manufacturers in the hemoglobin A1c testing market are investing in research & development to improve the accuracy of commercially-available HbA1c tests.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemoglobin A1c Testing Market
3.1. Market Overview
3.2. Introduction
3.3. Product Definition
3.4. Industry Evolution / Developments
4. Overview
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Global Hemoglobin A1c Testing Market Analysis and Forecast, 2017–2027
5. Key Insights
5.1. Recent Approved Brands for HbA1c Test, 2018
5.2. Global Hemoglobin A1c Testing Market: Regulations
5.3. Quantitative Analysis, by Test Type
5.4. Europe Hemoglobin A1c Testing Market Overview
6. Global Hemoglobin A1c Testing Market Analysis and Forecast, by Technology
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
6.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
6.3.2. Immunoassay
6.3.3. Boronate Affinity Chromatography
6.3.4. Direct Enzymatic Assay
6.3.5. Others
6.4. Global Hemoglobin A1c Testing Market Attractiveness, by Technology
7. Global Hemoglobin A1c Testing Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
7.3.1. Laboratory Testing
7.3.1.1. Commercial Laboratory
7.3.1.2. Others
7.3.2. Point-of-Care (POC) Testing
7.3.2.1. Hospitals
7.3.2.2. Homecare
7.3.2.3. Clinics
7.3.2.4. Others
7.4. Global Hemoglobin A1c Testing Market Attractiveness, by End-user
8. Global Hemoglobin A1c Testing Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Hemoglobin A1c Testing Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Hemoglobin A1c Testing Market Attractiveness, by Region
9. North America Hemoglobin A1c Testing Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. North America Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
9.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
9.3.2. Immunoassay
9.3.3. Boronate Affinity Chromatography
9.3.4. Direct Enzymatic Assay
9.3.5. Others
9.4. North America Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
9.4.1. Laboratory Testing
9.4.1.1. Commercial Laboratory
9.4.1.2. Others
9.4.2. Point-of-Care (POC) Testing
9.4.2.1. Hospitals
9.4.2.2. Homecare
9.4.2.3. Clinics
9.4.2.4. Others
9.5. North America Hemoglobin A1c Testing Market Value Forecast, by Country, 2017–2027
9.5.1. 1. U.S.
9.5.2. Canada
9.6. North America Hemoglobin A1c Testing Market Attractiveness Analysis
9.6.1. By Technology
9.6.2. By End-user
9.6.3. By Country
10. Europe Hemoglobin A1c Testing Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Europe Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
10.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
10.3.2. Immunoassay
10.3.3. Boronate Affinity Chromatography
10.3.4. Direct Enzymatic Assay
10.3.5. Others
10.4. Europe Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
10.4.1. Laboratory Testing
10.4.1.1. Commercial Laboratory
10.4.1.2. Others
10.4.2. Point-of-Care (POC) Testing
10.4.2.1. Hospitals
10.4.2.2. Homecare
10.4.2.3. Clinics
10.4.2.4. Others
10.5. Europe Hemoglobin A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Rest of Europe
10.6. Europe Hemoglobin A1c Testing Market Attractiveness Analysis
10.6.1. By Technology
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Hemoglobin A1c Testing Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Asia Pacific Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
11.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
11.3.2. Immunoassay
11.3.3. Boronate Affinity Chromatography
11.3.4. Direct Enzymatic Assay
11.3.5. Others
11.4. Asia Pacific Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
11.4.1. Laboratory Testing
11.4.1.1. Commercial Laboratory
11.4.1.2. Others
11.4.2. Point-of-Care (POC) Testing
11.4.2.1. Hospitals
11.4.2.2. Homecare
11.4.2.3. Clinics
11.4.2.4. Others
11.5. Asia Pacific Hemoglobin A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Asia Pacific Hemoglobin A1c Testing Market Attractiveness Analysis
11.6.1. By End-user
11.6.2. By Country/Sub-region
12. Latin America Hemoglobin A1c Testing Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Latin America Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
12.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
12.3.2. Immunoassay
12.3.3. Boronate Affinity Chromatography
12.3.4. Direct Enzymatic Assay
12.3.5. Others
12.4. Latin America Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
12.4.1. Laboratory Testing
12.4.1.1. Commercial Laboratory
12.4.1.2. Others
12.4.2. Point-of-Care (POC) Testing
12.4.2.1. Hospitals
12.4.2.2. Homecare
12.4.2.3. Clinics
12.4.2.4. Others
12.5. Latin America Hemoglobin A1c Testing Market Value Forecast, by Country/Sub-region, 2017–2027
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Latin America Hemoglobin A1c Testing Market Attractiveness Analysis
12.6.1. By Technology
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Hemoglobin A1c Testing Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Middle East & Africa Hemoglobin A1c Testing Market Value Forecast, by Technology, 2017–2027
13.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)
13.3.2. Immunoassay
13.3.3. Boronate Affinity Chromatography
13.3.4. Direct Enzymatic Assay
13.3.5. Others
13.4. Middle East & Africa Hemoglobin A1c Testing Market Value Forecast, by End-user, 2017–2027
13.4.1. Laboratory Testing
13.4.1.1. Commercial Laboratory
13.4.1.2. Others
13.4.2. Point-of-Care (POC) Testing
13.4.2.1. Hospitals
13.4.2.2. Homecare
13.4.2.3. Clinics
13.4.2.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2027
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Middle East & Africa Hemoglobin A1c Testing Market Attractiveness Analysis
13.6.1. By Technology
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis by Company (2018)
14.3. Company Profiles
14.3.1. Abbott Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. ARKRAY, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Bio-Rad Laboratories, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Polymer Technology Systems, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Danaher Corporation (Beckman Coulter)
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. F. Hoffmann-La Roche Ltd.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Menarini Group
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Sebia
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Siemens Healthineers
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Tosoh Corporation
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Trinity Biotech plc.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Financial Overview
14.3.11.3. Product Portfolio
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview